Estimates Revisions NewAmsterdam Pharma Company N.V. Deutsche Boerse AG
Stocks
KH6
NL00150012L7
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
11:25:01 01/10/26 pm AEST
|
After hours 06:00:02 am | |||
| 21.02 EUR | +5.42% |
|
21.50 | +2.31% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Frazier Lifesciences Acquisition Corporation(NAMS)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Frazier Lifesciences Acquisition Corporation(NAMS)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Frazier Lifesciences Acquisition Corporation(NAMS)
EBIT
Dividend / Share (DPS)
Data source:
Frazier Lifesciences Acquisition Corporation(NAMS)
Cash or Net Debt
- Stock Market
- Stocks
- NAMS Stock
- KH6 Stock
- Consensus NewAmsterdam Pharma Company N.V.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
